Search

everythinglearnresearchcommunity

for

Search:↓

The main goal for new Alopecia Areata treatments should be significant improvement in scalp hair growth.

Chronic cutaneous lupus erythematosus causes scarring, hair loss, and skin discoloration, especially on sun-exposed areas.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Pandemic stress worsens hair loss and skin issues, suggesting combined mental and skin care treatments.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

Platelet-Rich Plasma therapy helps increase hair density and regrowth for some types of hair loss.

The study suggests that analyzing DNA can help treat hair loss, but more research is needed.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Hair shedding that lasts more than 6 months may need medical tests, but often just reassurance is enough.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Higher levels of β-carotene and vitamin E may help prevent certain types of hair loss.

Tight hairstyles, especially on chemically treated hair, can cause reversible hair loss if caught early but may become permanent if not addressed.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Hair shedding that lasts over 6 months may need a closer look, but often just reassurance is enough.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.